Cargando…
Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemias arising from the malignant transformation of B-cell precursors (BCP-ALLs) are protected against chemotherapy by both intrinsic factors as well as by interactions with bone marrow stromal cells. Galectin-1 and Galectin-3 are lectins with overlapping specificity for bindi...
Autores principales: | Fei, Fei, Zhang, Mingfeng, Tarighat, Somayeh S., Joo, Eun Ji, Yang, Lu, Heisterkamp, Nora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694201/ https://www.ncbi.nlm.nih.gov/pubmed/36430839 http://dx.doi.org/10.3390/ijms232214359 |
Ejemplares similares
-
B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
por: Fei, Fei, et al.
Publicado: (2015) -
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
por: Tarighat, Somayeh S., et al.
Publicado: (2021) -
Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
por: Paz, Helicia, et al.
Publicado: (2018) -
Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia
por: Zhang, Mingfeng, et al.
Publicado: (2022) -
Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Tiago, et al.
Publicado: (2021)